Xeltis prepares for commercial launch after strong aXess trial results - PharmaTimes EU phase 3 data shows major gains in dialysis access performance

#nephrology #Xeltis #aXesstrialresults #aXessclinicaltrial #phase3trial #restorativevascularaccess #vascularaccess #haemodialyisis #primaryendpoint #endstagerenaldisease #haemodiaylisisvascularaccesstreatment #EndogenousTissueRestorationplatform #vascularaccess #dialysispatients
zurl.co/UPkoj

5/ 🧪 This study found correlations between the Cr/CysC ratio and variables like BMI, phosphorus, and uric acid. Interestingly, higher ratios correlated with reduced urea clearance (Kt/V). #Biomarkers #DialysisPatients #KidneyDisease